Research map: An exploratory pharmacokinetic-pharmacodynamic analysis of ceftazidime-avibactam and various blood biomarkers in patients with hospital-acquired pneumonia or ventilator-associated pneumonia caused by Klebsiella pneumoniae

Back to the article

Papers in this map

  1. C-reactive protein: a critical update · Mark B. Pepys · 2003 · 3446 citations · Cited by this paper
  2. Machine learning-based drug susceptibility prediction from Candida genomic data · 2026 · Related
  3. Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability · Erika Assarsson · 2014 · 1984 citations · Cited by this paper
  4. Emergence of dalbavancin non-susceptible methicillin-resistant Staphylococcus epidermidis (MRSE) in a patient treated with dalbavancin prolonged therapy: Case report, therapeutic drug monitoring and genomic characterization · 2026 · Related
  5. The C-reactive protein · Brian Clyne · 1999 · 682 citations · Cited by this paper
  6. Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacterales bacteraemia in high-risk neutropenic patients in haematology: A multicentre retrospective study · 2026 · Related
  7. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. · David M. Vigushin · 1993 · 644 citations · Cited by this paper
  8. Vancomycin penetration into intra-abdominal compartments: Site concentration disparities and implications for dose optimization in gram-positive infections · 2026 · Related
  9. From Therapeutic Drug Monitoring to Model‐Informed Precision Dosing for Antibiotics · Sebastian G. Wicha · 2021 · 317 citations · Cited by this paper
  10. Optimizing the Meropenem Dosing Regimen in Neonates: A Dual-Centre Cohort Study · 2026 · Related
  11. How to use biomarkers of infection or sepsis at the bedside: guide to clinicians · Pedro Manuel Sarmento Rodrigues Póvoa · 2023 · 301 citations · Cited by this paper
  12. A Novel blaTMB Allele Encoding a Functional Carbapenemase Associated with a Gamma-Mobile-Trio Island · 2026 · Related
  13. Interleukin-6 in Surgery, Trauma, and Critical Care Part II: Clinical Implications · Randeep Singh Jawa · 2010 · 234 citations · Cited by this paper
  14. Ecr positively regulates activity of the PhoQ/PhoP signalling system in Klebsiella pneumoniae · 2026 · Related
  15. Interleukin-6: a potential inflammatory marker after total joint replacement · Dieter-C. Wirtz · 2000 · 165 citations · Cited by this paper
  16. Broad-spectrum empirical antibiotic overuse in community-onset bacteraemia: Prevalence, outcomes, and associated factors · 2026 · Related
  17. A Physiologically Based Pharmacokinetic Modeling Approach to Predict Disease–Drug Interactions: Suppression of CYP3A by IL-6 · Krishna K. Machavaram · 2013 · 111 citations · Cited by this paper
  18. Arginine metabolism and compensatory adaptations expand the impaired phage resistance repertoire in colistin-resistant Acinetobacter baumannii · 2026 · Related
  19. Analytic Review: Interleukin-6 in Surgery, Trauma, and Critical Care: Part I: Basic Science · Randeep Singh Jawa · 2011 · 109 citations · Cited by this paper
  20. Vonoprazan-Based Dual and Quadruple Therapy with Varying Duration for Helicobacter pylori Eradication: A Multicenter, Randomized Controlled Trial · 2026 · Related
  21. Ceftazidime‐Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups · Jianguo Li · 2018 · 104 citations · Cited by this paper
  22. An approach to antibiotic treatment in patients with sepsis · María Luisa Martínez · 2020 · 100 citations · Cited by this paper
  23. Towards precision medicine: Therapeutic drug monitoring–guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity · Jaclyn A. Cusumano · 2020 · 95 citations · Cited by this paper
  24. PopED: An extended, parallelized, nonlinear mixed effects models optimal design tool · Joakim Nyberg · 2012 · 89 citations · Cited by this paper
  25. Therapeutic Drug Monitoring of Antibiotics: Defining the Therapeutic Range · Mohd Hafiz Abdul-Aziz · 2021 · 74 citations · Cited by this paper
  26. Biomarker‐Guided Individualization of Antibiotic Therapy · Linda B. S. Aulin · 2021 · 66 citations · Cited by this paper
  27. Kinetics of c-reactive protein (CRP) and serum amyloid A protein (SAA) in patients with community-acquired pneumonia (CAP), as presented with biologic half-life times · Saori Takata · 2011 · 53 citations · Cited by this paper
  28. Pharmacokinetic and Pharmacodynamic Analysis of Ceftazidime/Avibactam in Critically Ill Patients · Gary E. Stein · 2018 · 53 citations · Cited by this paper
  29. Pivotal Role of Translation in Anti‐Infective Development · Lena E. Friberg · 2021 · 34 citations · Cited by this paper
  30. Current treatment of nosocomial pneumonia and ventilator-associated pneumonia · Erika Paola Plata-Menchaca · 2022 · 27 citations · Cited by this paper
  31. Cost-effectiveness Comparison of Ceftazidime/Avibactam Versus Meropenem in the Empirical Treatment of Hospital-acquired Pneumonia, Including Ventilator-associated Pneumonia, in Italy · Eszter Tichy · 2020 · 18 citations · Cited by this paper
  32. The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin‐6 and C‐reactive protein by modelling · Ida Netterberg · 2017 · 17 citations · Cited by this paper
  33. Monte Carlo Simulation Methodologies for β‐Lactam/β‐Lactamase Inhibitor Combinations: Effect on Probability of Target Attainment Assessments · James M. Kidd · 2019 · 13 citations · Cited by this paper
  34. Therapeutic drug monitoring (TDM) of β-lactam/β-lactamase inhibitor (BL/BLI) drug combinations: insights from a pharmacometric simulation study · Amaury O’Jeanson · 2024 · 11 citations · Cited by this paper

Source: OpenAlex (CC0)